76003-30-0 Usage
Description
2-METHYL-3-OXO-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, also known as tert-butyl 2-methyl-3-oxopiperazine-1-carboxylate, is a colorless liquid with the molecular formula C11H19N3O3. It is a derivative of piperazine and is commonly used as a building block in the synthesis of pharmaceuticals and other organic compounds. This chemical is soluble in organic solvents and has a faint odor. Due to its potential to cause irritation to the eyes, skin, and respiratory system, it is important to handle this chemical with caution.
Uses
Used in Pharmaceutical Industry:
2-METHYL-3-OXO-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a building block for the synthesis of various pharmaceuticals and organic compounds. Its unique chemical structure allows it to be incorporated into a wide range of molecules, contributing to the development of new drugs and therapeutic agents.
Used in Organic Chemistry:
2-METHYL-3-OXO-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a versatile reagent in organic chemistry for the synthesis of various organic compounds. Its ability to form stable intermediates and participate in a range of chemical reactions makes it a valuable tool for organic synthesis.
Used in Research and Development:
2-METHYL-3-OXO-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a research compound in the development of new chemical processes and methodologies. Its unique properties and reactivity make it an interesting subject for scientific investigation, potentially leading to new discoveries and applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 76003-30-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,0,0 and 3 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 76003-30:
(7*7)+(6*6)+(5*0)+(4*0)+(3*3)+(2*3)+(1*0)=100
100 % 10 = 0
So 76003-30-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H18N2O3/c1-7-8(13)11-5-6-12(7)9(14)15-10(2,3)4/h7H,5-6H2,1-4H3,(H,11,13)
76003-30-0Relevant articles and documents
Selective NK-3 receptor antagonist, preparation and application thereof
-
Paragraph 0074-0075; 0079-0081, (2020/11/09)
The invention provides a selective NK-3 receptor antagonist, preparation and application thereof, particularly a compound represented by the following formula (I). The compound of the invention has unexpected activity to modulate cytokines and/or interferon, and is useful in the treatment of CNS and peripheral diseases or disorders.
Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists
Rudolph, Dale A.,Alcazar, Jesus,Ameriks, Michael K.,Anton, Ana Belen,Ao, Hong,Bonaventure, Pascal,Carruthers, Nicholas I.,Chrovian, Christa C.,De Angelis, Meri,Lord, Brian,Rech, Jason C.,Wang, Qi,Bhattacharya, Anindya,Andres, Jose Ignacio,Letavic, Michael A.
, p. 3157 - 3163 (2015/07/08)
Abstract The optimization efforts that led to a novel series of methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones that are potent rat and human P2X7 antagonists are described. These efforts resulted in the discovery of co
HETEROCYCLIC COMPOUNDS
-
Page/Page column 16, (2009/02/11)
The invention is concerned with novel heterocyclyl compounds of formula (I) wherein A, X, Y, R3, R4, R5, R6, R7, R8, R9, R10, m and n are as herein defined, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.
